Enrolling by invitationPhase 1NCT07178327

Phase I Clinical Study to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of LYN101

Studying Becker muscular dystrophy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Shanghai TTM-Bio Technology Co., Ltd
Principal Investigator
Huan Zhou
The First Affiliated Hospital of Bengbu Medical University
Intervention
LYN101(drug)
Enrollment
44 enrolled
Eligibility
18-70 years · All sexes
Timeline
20252027

Study locations (2)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07178327 on ClinicalTrials.gov

Other trials for Becker muscular dystrophy

Additional recruiting or active studies for the same condition.

See all trials for Becker muscular dystrophy

← Back to all trials